| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H0011 |
Alcohol and/or drug services; acute detoxification (residential addiction program inpatient) |
36,572 |
2,310 |
$9.35M |
| T2023 |
Targeted case management; per month |
16,586 |
15,256 |
$5.06M |
| H2020 |
Therapeutic behavioral services, per diem |
13,634 |
1,240 |
$2.57M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
10,038 |
760 |
$1.83M |
| H2034 |
Alcohol and/or drug abuse halfway house services, per diem |
7,770 |
601 |
$1.77M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
17,730 |
10,216 |
$791K |
| H0038 |
Self-help/peer services, per 15 minutes |
28,682 |
16,449 |
$511K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
4,565 |
638 |
$484K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,166 |
6,573 |
$475K |
| 90832 |
Psychotherapy, 30 minutes with patient |
15,654 |
8,990 |
$469K |
| H2027 |
Psychoeducational service, per 15 minutes |
3,152 |
1,001 |
$244K |
| T1007 |
Alcohol and/or substance abuse services, treatment plan development and/or modification |
3,055 |
2,633 |
$154K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,391 |
970 |
$139K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
703 |
528 |
$90K |
| 90791 |
Psychiatric diagnostic evaluation |
1,260 |
1,152 |
$87K |
| H2015 |
Comprehensive community support services, per 15 minutes |
2,093 |
682 |
$59K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
530 |
464 |
$45K |
| H0001 |
Alcohol and/or drug assessment |
703 |
644 |
$38K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
538 |
493 |
$28K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,197 |
532 |
$10K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
180 |
158 |
$9K |
| 99406 |
|
554 |
422 |
$3K |
| 90834 |
Psychotherapy, 45 minutes with patient |
61 |
53 |
$3K |
| 99215 |
Prolong outpt/office vis |
46 |
29 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
54 |
38 |
$2K |
| H0025 |
Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) |
155 |
82 |
$2K |
| 99205 |
Prolong outpt/office vis |
16 |
12 |
$1K |
| 90839 |
|
24 |
13 |
$882.08 |
| 36415 |
Collection of venous blood by venipuncture |
18 |
17 |
$11.16 |
| 99051 |
|
140 |
125 |
$0.00 |
| 99000 |
|
18 |
17 |
$0.00 |